Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia

Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia

BackgroundAmino acid (AA) metabolism plays a crucial role in cancer. However, its role in acute myeloid leukemia (AML) is still unavailable. We screened out AA metabolic genes, which related to prognosis, and analyzed their correlation with tumor immune microenvironment in AML.MethodsWe evaluated 47...

Full description

Bibliographic Details
Main Authors:	Hui Zhou, Fengjuan Wang, Ting Niu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Nutrition
Subjects:	amino acid metabolism prognosis tumor microenvironment immunotherapy acute myeloid leukemia
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2022.1056648/full

Similar Items

Development and validation of a disulfidptosis-related scoring system to predict clinical outcome and immunotherapy response in acute myeloid leukemia by integrated analysis of single-cell and bulk RNA-sequencing
by: Fangmin Zhong, et al.
Published: (2023-11-01)

Immune‐related gene signature predicts clinical outcomes and immunotherapy response in acute myeloid leukemia
by: Qiang Xu, et al.
Published: (2022-09-01)

Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products
by: Christopher Hino, et al.
Published: (2022-06-01)

Aggrephagy-related patterns in tumor microenvironment, prognosis, and immunotherapy for acute myeloid leukemia: a comprehensive single-cell RNA sequencing analysis
by: Yan Pan, et al.
Published: (2023-07-01)

A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia
by: Hai-Bin Zhang, et al.
Published: (2022-08-01)

Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia
by: Jingjing Pan, et al.
Published: (2022-06-01)

Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia
by: Tingting Chen, et al.
Published: (2024-11-01)

Editorial: Immunotherapy in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
by: Omer Jamy, et al.
Published: (2024-10-01)

Fatty acid metabolism predicts prognosis and NK cell immunosurveillance of acute myeloid leukemia patients
by: Zhitao Ye, et al.
Published: (2022-10-01)

The pyroptosis-related gene signature predicts prognosis and reveals characterization of the tumor immune microenvironment in acute myeloid leukemia
by: Tao Zhou, et al.
Published: (2022-08-01)

Establishment and verification of a TME prognosis scoring model based on the acute myeloid leukemia single-cell transcriptome
by: Peiwen Miao, et al.
Published: (2024-08-01)

Integrated bioinformatic analysis of mitochondrial metabolism-related genes in acute myeloid leukemia
by: Xiqin Tong, et al.
Published: (2023-04-01)

Dissecting the Immune Landscape of Acute Myeloid Leukemia
by: Jan Davidson-Moncada, et al.
Published: (2018-11-01)

Comprehensive analysis for cellular senescence-related immunogenic characteristics and immunotherapy prediction of acute myeloid leukemia
by: Yan Mao, et al.
Published: (2022-09-01)

An immune-related gene prognostic index for acute myeloid leukemia associated with regulatory T cells infiltration
by: Qiongni Xie, et al.
Published: (2022-12-01)

Immunotherapy in Acute Myeloid Leukemia: A Literature Review of Emerging Strategies
by: Luca Guarnera, et al.
Published: (2023-10-01)

Identification of a prognostic model based on costimulatory molecule-related subtypes and characterization of tumor microenvironment infiltration in acute myeloid leukemia
by: Yan Mao, et al.
Published: (2022-08-01)

The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia
by: Xiuhua Su, et al.
Published: (2022-10-01)

Editorial: Immunobiology and immunotherapeutics in myelodysplastic syndrome and acute myeloid leukemia
by: Shyam A. Patel, et al.
Published: (2024-10-01)

Strategy of Targeted T Cell Immunotherapy for Acute Myeloid Leukemia
by: LI Yangqiu
Published: (2024-04-01)

The potential role of the thymus in immunotherapies for acute myeloid leukemia
by: Christopher Hino, et al.
Published: (2023-02-01)

Immunotherapy-relevance of a candidate prognostic score for Acute Myeloid Leukemia
by: Yiyun Pan, et al.
Published: (2024-06-01)

ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia
by: Ran Li, et al.
Published: (2022-08-01)

Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia
by: Peng Ke, et al.
Published: (2023-11-01)

The cytokine network in acute myeloid leukemia
by: Michela Luciano, et al.
Published: (2022-09-01)

Comprehensive characterization of immunogenic cell death in acute myeloid leukemia revealing the association with prognosis and tumor immune microenvironment
by: Yongyu Chen, et al.
Published: (2024-04-01)

MICAL1 promotes the proliferation in acute myeloid leukemia and is associated with clinical prognosis and immune infiltration
by: Yinsen Song, et al.
Published: (2024-07-01)

m5C regulator‐mediated methylation modification patterns and tumor microenvironment infiltration characteristics in acute myeloid leukemia
by: Qiang Wen, et al.
Published: (2024-01-01)

Proteomic and metabolomic exploration in relapse acute myeloid leukemia bone marrow supernatant combined with genetic characteristics
by: Xinyao Ji, et al.
Published: (2024-12-01)

CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand?
by: Daniela Damiani, et al.
Published: (2024-05-01)

CYTOGENETIC FINDINGS IN ACUTE MYELOID LEUKEMIA
by: Gh. Toogeh, et al.
Published: (2003-08-01)

<i>TP53</i> Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective
by: Federico Zingarelli, et al.
Published: (2022-11-01)

A distinct lipid metabolism signature of acute myeloid leukemia with prognostic value
by: Ding Li, et al.
Published: (2022-07-01)

Ferroptosis-related molecular patterns reveal immune escape, inflammatory development and lipid metabolism characteristics of the tumor microenvironment in acute myeloid leukemia
by: Fang-Min Zhong, et al.
Published: (2022-11-01)

A Review of Efficacy and Safety of Checkpoint Inhibitor for the Treatment of Acute Myeloid Leukemia
by: Dan Liao, et al.
Published: (2019-06-01)

Development of a novel pyroptosis-related LncRNA signature with multiple significance in acute myeloid leukemia
by: Guangcai Zhong, et al.
Published: (2023-01-01)

Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
by: Isabel Castro, et al.
Published: (2019-08-01)

A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges
by: Ying Chen, et al.
Published: (2023-04-01)

Clinical outcome and prognosis of patients with acute myeloid leukemia submitted to chemotherapy with 5 years of follow-up
by: Kaira Mara Cordeiro de Albuquerque, M.Sc, et al.
Published: (2024-01-01)

Monocytic Myeloid-Derived Suppressor Cells But Not Monocytes Predict Poor Prognosis of Acute Myeloid Leukemia
by: Xiyang Ren, et al.
Published: (2022-11-01)